MedPageToday does a good job of balanced reporting on this issue. My feeling is that there are clear times when drug elluting stents are of value: when patients can take aspirin and clopidogrel (Plavix). If the patient is looking at surgery soon (knee replacement/hip replacement, etc.), then bare metal stents might be best.
We'll have to wait for more trials....
But it DOES appear clear that it is prudent to continue anti-platelet therapy after stenting for AT LEAST a year. I think our guys are continuing it indefinitely, if its tolerated.